Holen Sie sich die Stockscreener-App
30.50
0.53%
0.16
Handel nachbörslich:
30.49
-0.01
-0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$30.34
Offen:
$30.1
24-Stunden-Volumen:
2.30M
Relative Volume:
1.32
Marktkapitalisierung:
$4.84B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-277.27
EPS:
-0.11
Netto-Cashflow:
$-28.11M
1W Leistung:
+2.31%
1M Leistung:
-1.07%
6M Leistung:
-14.35%
1J Leistung:
+6.01%
1-Tages-Spanne:
$29.57
$30.64
1-Wochen-Bereich:
$28.82
$30.64
52-Wochen-Spanne:
$25.28
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Vergleichen Sie TGTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
30.50 | 4.82B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2024-10-29 | Eingeleitet | TD Cowen | Buy |
| 2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-26 | Fortgesetzt | Jefferies | Buy |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
| 2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-04-25 | Eingeleitet | Jefferies | Buy |
| 2017-03-06 | Bestätigt | FBR & Co. | Outperform |
| 2016-10-06 | Fortgesetzt | Brean Capital | Buy |
| 2016-05-27 | Eingeleitet | SunTrust | Buy |
| 2015-12-01 | Eingeleitet | FBR Capital | Outperform |
| 2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
| 2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-19 | Bestätigt | Brean Capital | Buy |
| 2014-12-11 | Bestätigt | ROTH Capital | Buy |
| 2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
Will TG Therapeutics Inc. (NKB2) stock outperform global peers2025 Earnings Surprises & Low Risk Investment Opportunities - ulpravda.ru
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Is TG Therapeutics Inc a good long term investmentBear Market Strategies & Follow Top Performers in the Community - earlytimes.in
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN
Discipline and Rules-Based Execution in TGTX Response - Stock Traders Daily
TG Therapeutics: What Wall Street Isn't Telling You (NASDAQ:TGTX) - Seeking Alpha
Why TG Therapeutics Stock Was Soaring This Week - MSN
Could The Market Be Wrong About TG Therapeutics, Inc. (NASDAQ:TGTX) Given Its Attractive Financial Prospects? - simplywall.st
Investing in TG Therapeutics (NASDAQ:TGTX) three years ago would have delivered you a 160% gain - Yahoo Finance
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Osaic Holdings Inc. Sells 39,445 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics Earnings Notes - Trefis
Trading the Move, Not the Narrative: (TGTX) Edition - Stock Traders Daily
Is the options market predicting a spike in TG Therapeutics stock? - MSN
TG Therapeutics (MIL:1TGTX) EV-to-OCF : -66.83 (As of Dec. 22, 2025) - GuruFocus
TG Therapeutics (STU:NKB2) EV-to-FCF : -66.70 (As of Dec. 21, 2025) - GuruFocus
TG Therapeutics (STU:NKB2) EV-to-OCF : -66.83 (As of Dec. 21, 2025) - GuruFocus
Will TG Therapeutics Inc. stock remain a Wall Street favorite2025 Support & Resistance & Consistent Profit Trading Strategies - Улправда
Can TG Therapeutics Inc. stock surprise with earnings upsideQuarterly Earnings Report & Technical Pattern Based Signals - Улправда
Can TG Therapeutics Inc. stock sustain institutional interest2025 Market Overview & Short-Term Trading Alerts - DonanımHaber
Is the Options Market Predicting a Spike in TG Therapeutics Stock? - Zacks Investment Research
How buybacks impact TG Therapeutics Inc. stock valueTrade Risk Report & Free Risk Controlled Daily Trade Plans - Улправда
Can TG Therapeutics Inc. stock resist sector downturns2025 Earnings Surprises & Daily Profit Maximizing Tips - Улправда
Is TG Therapeutics Inc. (NKB2) stock expanding market penetration2025 Trade Ideas & AI Forecasted Entry and Exit Points - ulpravda.ru
Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда
Earnings Recap: Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Snapshot & Risk Controlled Stock Alerts - Улправда
Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда
Why TG Therapeutics Inc. stock remains on watchlistsJuly 2025 Highlights & Community Driven Trade Alerts - Улправда
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - sharewise.com
Marex Group plc Makes New $10.02 Million Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eventide Asset Management LLC Increases Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
(TGTX) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Norges Bank Makes New Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Bought by Diadema Partners LP - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Jump Financial LLC - MarketBeat
Is TG Therapeutics (TGTX) Quietly Reframing Its Investment Story Around Neurology Depth Over Breadth? - Sahm
1832 Asset Management L.P. Has $5.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Lacklustre Performance Is Driving TG Therapeutics, Inc.'s (NASDAQ:TGTX) Low P/S - 富途牛牛
New York State Common Retirement Fund Boosts Stake in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. $TGTX Shares Bought by Russell Investments Group Ltd. - MarketBeat
Is TG Therapeutics Inc. (NKB2) stock nearing a technical breakout2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Is TG Therapeutics Still Attractively Priced After Recent Multiple Sclerosis Expansion Progress? - Sahm
Why TG Therapeutics Inc. (NKB2) stock stays resilient2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
TG Therapeutics (TGTX) Earnings Date and Reports 2026 - MarketBeat
TG Therapeutics (TGTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
With TG Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Legal & General Group Plc Has $13.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Prudential Financial Inc. - MarketBeat
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):